Acasă › Boala Crohn › Texas
Studii clinice pentru Boala Crohn în Texas
35 studii pentru Boala Crohn caută participanți în Texas.
Orașe în Texas
- Houston17 studii
- Tyler16 studii
- San Antonio15 studii
- Dallas10 studii
- Lubbock10 studii
- Lewisville9 studii
- Round Rock7 studii
- Fort Worth6 studii
- The Woodlands6 studii
- Arlington5 studii
- Garland4 studii
- Austin3 studii
- League City3 studii
Text oficial al studiului (în engleză)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- și încă 3
În curs de recrutareFaza 3
Toate vârstele · Toate sexele · Actualizat 2 oct. 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Baylor University Medical Center ( Site 5031), Dallas
- Epic Medical Research - Mesquite ( Site 5153), Denton
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- și încă 6
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 2 oct. 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- și încă 9
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- și încă 7
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 30 sept. 2026 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 25 sept. 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gi Alliance - Cedar Park /ID# 268153, Cedar Park
- Houston Methodist Hospital /ID# 265533, Houston
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
- și încă 3
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- DFW Clinical Trials, Carrollton
- Lubbock Gastroenterology, Lubbock
- Gastroenterology Research of America, LLC, San Antonio
- și încă 2
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Baylor University Medical Center, Dallas
- și încă 5
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
În curs de recrutareFaza 3
Vârste de 3 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Novel Research, LLC, Bellaire
- One of a Kind Clinical research Center TX LLC, Kingwood
- Southern Star Research Institute, LLC, San Antonio
- și încă 1
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- și încă 2
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Inquest Clinical Research-Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas
- Valley Institute of Research-Site Number: 8400004, Harlingen
- și încă 8
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 23 sept. 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
- SMS Clinical Research-Site Number: 8400035, Mesquite
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
- și încă 2
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 23 sept. 2026 · NCT07184944A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- și încă 3
În curs de recrutareFaza 2
Vârste de la 18 la 85 · Toate sexele · Actualizat 22 sept. 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
În curs de recrutareFaza 3
Vârste de la 2 la 19 · Toate sexele · Actualizat 22 sept. 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Texas Digestive Disease Consultants Cedar Park, Cedar Park
- GI Alliance - Digestive Health Associates of Texas, Dallas
- The University of Texas Health Science Center at Houston, Houston
- și încă 7
În curs de recrutareFaza 4
Vârste de la 18 la 70 · Toate sexele · Actualizat 9 sept. 2026 · NCT06045754Standardized Microbiota Transplant Therapy in Crohn's Disease
- UT Southwestern, Dallas
În curs de recrutareFaza 2
Vârste de la 18 la 89 · Toate sexele · Actualizat 8 sept. 2026 · NCT06631586A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 aug. 2026 · NCT04372108A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Tyler Research Institute, LLC, Tyler
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 aug. 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 24 aug. 2026 · NCT05509777Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
În curs de recrutare
Vârste de 18 ani și peste · Toate sexele · Actualizat 7 aug. 2026 · NCT05230173HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
În curs de recrutareFaza 2
Vârste de la 18 la 65 · Toate sexele · Actualizat 6 aug. 2026 · NCT07077746A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
În curs de recrutareFaza 3
Vârste de la 18 la 65 · Toate sexele · Actualizat 27 mai 2026 · NCT06227910A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 22 mai 2026 · NCT06764615Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 20 mai 2026 · NCT04751396A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
În curs de recrutareFaza 3
Vârste de 2 ani și peste · Toate sexele · Actualizat 7 mai 2026 · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Texas Children's Hospital, Houston
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 5 mai 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Central Texas Clinical Research, LLC, Austin
- Inquest Clinical Research, Baytown
- Novel Research, LLC, Bellaire
- și încă 8
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 27 apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400002, Fredericksburg
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 27 mar. 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- și încă 5
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 12 mar. 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Houston Methodist Hospital, Houston
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 15 ian. 2026 · NCT06257706Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
În curs de recrutareStudiu observațional
Vârste de la 18 la 100 · Toate sexele · Actualizat 18 mai 2021 · NCT04617184Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.